Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Ritlecitinib was generally well tolerated in children with alopecia areata.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Reflectance confocal microscopy is a promising non-invasive tool for diagnosing alopecia areata incognita.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

PRP gel is a safe, affordable treatment needing trained staff and proper facilities.

Reflectance confocal microscopy can help tell apart scarring from non-scarring hair loss.

Calcitriol-resistant rickets is an inherited disorder that affects hair growth and causes hair loss.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Topical IKKα inhibitors may help prevent CCS tumours.

Circular RNA ERCC6 helps activate stem cells important for cashmere goat hair growth by interacting with specific molecules in an m6A modification-dependent way.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

ICMR created standard treatment guidelines for skin diseases to improve care across India.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

The method greatly improves low-light sports images' quality and reduces artifacts.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

New genetic mutations linked to rare skin disorders were found in three newborns.